JP2023526791A5 - - Google Patents

Info

Publication number
JP2023526791A5
JP2023526791A5 JP2022569555A JP2022569555A JP2023526791A5 JP 2023526791 A5 JP2023526791 A5 JP 2023526791A5 JP 2022569555 A JP2022569555 A JP 2022569555A JP 2022569555 A JP2022569555 A JP 2022569555A JP 2023526791 A5 JP2023526791 A5 JP 2023526791A5
Authority
JP
Japan
Prior art keywords
alkyl
group
independently selected
halogenated
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022569555A
Other languages
English (en)
Japanese (ja)
Other versions
JP7774312B2 (ja
JP2023526791A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/095191 external-priority patent/WO2021233427A1/zh
Publication of JP2023526791A publication Critical patent/JP2023526791A/ja
Publication of JP2023526791A5 publication Critical patent/JP2023526791A5/ja
Application granted granted Critical
Publication of JP7774312B2 publication Critical patent/JP7774312B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022569555A 2020-05-21 2021-05-21 縮合環化合物、それらの製造方法、医薬組成物、およびそれらの使用 Active JP7774312B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202010433988 2020-05-21
CN202010433988.6 2020-05-21
CN202110529033 2021-05-14
CN202110529033.5 2021-05-14
PCT/CN2021/095191 WO2021233427A1 (zh) 2020-05-21 2021-05-21 并环化合物及其制备方法、药物组合物和应用

Publications (3)

Publication Number Publication Date
JP2023526791A JP2023526791A (ja) 2023-06-23
JP2023526791A5 true JP2023526791A5 (https=) 2024-05-23
JP7774312B2 JP7774312B2 (ja) 2025-11-21

Family

ID=78672734

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022569555A Active JP7774312B2 (ja) 2020-05-21 2021-05-21 縮合環化合物、それらの製造方法、医薬組成物、およびそれらの使用

Country Status (8)

Country Link
US (1) US20230192683A1 (https=)
EP (1) EP4155305A4 (https=)
JP (1) JP7774312B2 (https=)
KR (1) KR20230015333A (https=)
CN (2) CN115991703A (https=)
AU (1) AU2021276301A1 (https=)
TW (1) TWI910166B (https=)
WO (1) WO2021233427A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI860849B (zh) 2021-09-14 2024-11-01 美商美國禮來大藥廠 Sstr4促效劑鹽
KR20240122964A (ko) 2023-02-06 2024-08-13 에이치엘만도 주식회사 피스톤 밸브 조립체 및 이를 구비한 쇼크 업소버
JP2026509366A (ja) 2023-03-10 2026-03-18 イーライ リリー アンド カンパニー Sstr4アゴニスト及びその塩の調製のための方法
AU2024236692A1 (en) 2023-03-10 2025-10-16 Eli Lilly And Company Methods for the preparation and dose regimens for use of sstr4 agonists and salts thereof
WO2024245077A1 (zh) * 2023-05-29 2024-12-05 武汉熙瑞医药科技有限公司 3-氮杂-双环[3.1.0]己烷衍生物、其制备方法及其应用
WO2025096300A1 (en) 2023-10-30 2025-05-08 Eli Lilly And Company Novel methods for the preparation of 3-azabicylco[3.1,0]hexane-6-carboxamide derivatives
CN120965687A (zh) * 2024-05-17 2025-11-18 广州费米子科技有限责任公司 Sstr4激动剂类化合物的晶体形式及其制备方法和用途
WO2025247982A1 (en) 2024-05-29 2025-12-04 Grünenthal GmbH Piperazines which act as sstr4 modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2685828A4 (en) * 2011-03-17 2014-08-13 Merck Sharp & Dohme SUBSTITUTED 3-AZABICYCLO [3,1,0-] HEXAN DERIVATIVES AS CCR2 ANTAGONISTS
KR101556318B1 (ko) * 2013-05-15 2015-10-01 한국과학기술연구원 칼슘이온 채널 조절제로서 유효한 6-피라졸일아미도-3-치환된 아자바이사이클로[3.1.0]헥산 유도체
US9371282B2 (en) * 2013-05-17 2016-06-21 Centrexion Therapeutics Corporation Somatostatin receptor subtype 4 (SSTR4) agonists
EP3045448A4 (en) 2013-09-12 2017-01-25 Sumitomo Chemical Company Limited Nitrogen-containing saturated heterocyclic compound
CN105315293A (zh) * 2014-07-29 2016-02-10 上海科州药物研发有限公司 作为蛋白激酶抑制剂的杂环化合物及其制备方法和用途

Similar Documents

Publication Publication Date Title
JP2023526791A5 (https=)
US6673799B1 (en) Cyanophenyl derivative
JP7502337B2 (ja) Kras g12cインヒビター及びその使用
KR102309986B1 (ko) 사이클린 의존성 키나아제 cdk9의 신규 인히비터
EP1256576B1 (en) Fused imidazolium derivatives
IL268030B2 (en) Bicyclics as allosteric shp2 inhibitors
JP2023528394A (ja) 大環状jak阻害剤およびその適用
US20250066342A1 (en) Cycloalkylurea derivative
ES3062921T3 (en) Preparation method for novel rho-related protein kinase inhibitor and intermediate in preparation method
JP2008528467A5 (https=)
CN107922418A (zh) 抗微生物化合物及制备和使用所述化合物的方法
WO2019200202A1 (en) Antagonists of human integrin (alpha4)(beta7)
AU2019344107B2 (en) N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors
WO2019079485A1 (en) AMINO-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND DERIVATIVES THEREOF
JP2018525363A (ja) 疼痛に対する多様な活性を有する置換アミド誘導体
KR102926129B1 (ko) 사이클린 의존성 키나아제 9 억제제로서의 화합물 및 그의 용도
FR2943669A1 (fr) Derives de nicotinamide,leur preparation et leur application en therapeutique
JP2014520108A5 (https=)
BR112017010402B1 (pt) Carboxamida substituída à base de tiazol e oxazol e derivados de ureia como ligantes de receptor vanilóide ii
JP2023528073A (ja) Gpr65モジュレーターとしてのn-フェニルアミノカルボニル、ピリジノ-、ピリミジノ及びベンゾトロパン
JP2024511389A5 (https=)
RU2444515C2 (ru) Производное амида индазолакриловой кислоты
KR20260006627A (ko) 헤테로방향족 인돌설폰아미드
JP2022510700A5 (https=)
ES3013859T3 (en) Mdm2 inhibitor, preparation method therefor, pharmaceutical composition thereof, and use thereof